In part 1 of this Exclusive Interview, Adam Brown talks with Diabetes in Control Publisher Steve Freed about ferreting out the latest technology to share with consumers.

In part 2 of this Exclusive Interview, Adam Brown talks with Diabetes in Control Publisher Steve Freed about his interest in the apps that help patients to make decisions in their diabetes management.

In part 3 of this Exclusive Interview, Adam Brown talks with Diabetes in Control Publisher Steve Freed about the hindrances to the more widespread use of CGMs and solutions.

In part 4 of this Exclusive Interview, Adam Brown talks with Diabetes in Control Publisher Steve Freed about his thoughts on further CGM development and the advancements in the closed loop system.

Currently, there is no effective generic alternative to brand-name insulin

Glycemic control not better in 2010 to 2018, despite more use of insulin pumps, continuous monitoring

Now that the cold cold weather of winter is upon us I am especially glad I live in Florida. As I am writing this, it is a chilly 61 degrees. Although most of you would love for it to be that warm where you are, there are some problems in …

Study assesses glycemic variability via continuous glucose monitoring and compares it against incidence of diabetic retinopathy to determine if correlation exists.

Development of diabetic retinopathy found to be significantly reduced.

Automatic information processing studied to help find diabetic retinopathy on a larger scale.